Patents by Inventor Na Gan

Na Gan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11426418
    Abstract: What is disclosed is a controlled release pharmaceutical composition comprising a biocompatible and bioerodible semi-solid gel comprising a mixture of a triglyceride of ricinoleic acid and a gelling agent, in a formulation with loteprednol, latanoprost, celecoxib, triamcinolone, or betamethasone and, optionally, a second corticosteroid, analgesic, or anti-inflammatory agent.
    Type: Grant
    Filed: February 17, 2020
    Date of Patent: August 30, 2022
    Assignee: MIRA PHARMA CORPORATION
    Inventors: Hui Rong Shen, Na Gan
  • Publication number: 20200179406
    Abstract: What is disclosed is a controlled release pharmaceutical composition comprising a biocompatible and bioerodible semi-solid gel comprising a mixture of a triglyceride of ricinoleic acid and a gelling agent, in a formulation with loteprednol, latanoprost, celecoxib, triamcinolone, or betamethasone and, optionally, a second corticosteroid, analgesic, or anti-inflammatory agent.
    Type: Application
    Filed: February 17, 2020
    Publication date: June 11, 2020
    Inventors: Hui Rong Shen, Na Gan
  • Patent number: 10561606
    Abstract: What is disclosed is a controlled release pharmaceutical composition comprising a biocompatible and bioerodible semi-solid gel comprising a triglyceride of ricinoleic acid, a gelling agent, bupivacaine and, optionally, a corticosteroid, an analgesic, or an anti-inflammatory agent.
    Type: Grant
    Filed: December 6, 2018
    Date of Patent: February 18, 2020
    Assignee: Mira Pharma Corporation
    Inventors: Hui Rong Shen, Na Gan
  • Patent number: 10500281
    Abstract: What is disclosed is a semi-solid controlled release pharmaceutical composition containing biocompatible and bioerodible semi-solid lipid matrix incorporating local anesthetics agents to form a semi-solid solution, a method of using the pharmaceutical composition to treat, and a method of making the pharmaceutical composition.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: December 10, 2019
    Assignee: Mira Pharma Corporation
    Inventors: Hui Rong Shen, Na Gan
  • Publication number: 20190167574
    Abstract: What is disclosed is a controlled release pharmaceutical composition comprising a biocompatible and bioerodible semi-solid gel comprising a triglyceride of ricinoleic acid, a gelling agent, bupivacaine and, optionally, a corticosteroid, an analgesic, or an anti-inflammatory agent.
    Type: Application
    Filed: December 6, 2018
    Publication date: June 6, 2019
    Inventors: Hui Rong Shen, Na Gan
  • Patent number: 10220093
    Abstract: What is described is a semi-solid controlled release composition comprising a semi-solid lipid and bupivacaine in a solution or a homogenous suspension, methods of using the composition for treating a disease, and methods of manufacturing the composition.
    Type: Grant
    Filed: December 6, 2017
    Date of Patent: March 5, 2019
    Assignee: Mira Pharma Corporation
    Inventors: Hui Rong Shen, Na Gan
  • Publication number: 20180104340
    Abstract: What is described is a semi-solid controlled release composition comprising a semi-solid lipid and bupivacaine in a solution or a homogenous suspension, methods of using the composition for treating a disease, and methods of manufacturing the composition.
    Type: Application
    Filed: December 6, 2017
    Publication date: April 19, 2018
    Inventors: Hui Rong Shen, Na Gan
  • Patent number: 9849180
    Abstract: What is described is a semi-solid controlled release composition comprising a semi-solid lipid pharmaceutical active agent in a solution or a homogenous suspension, methods of using the composition for treating a disease, and methods of manufacturing the composition.
    Type: Grant
    Filed: September 14, 2015
    Date of Patent: December 26, 2017
    Inventors: Hui Rong Shen, Na Gan
  • Publication number: 20160074513
    Abstract: What is described is a semi-solid controlled release composition comprising a semi-solid lipid pharmaceutical active agent in a solution or a homogenous suspension, methods of using the composition for treating a disease, and methods of manufacturing the composition.
    Type: Application
    Filed: September 14, 2015
    Publication date: March 17, 2016
    Inventors: Hui Rong Shen, Na Gan
  • Publication number: 20150366967
    Abstract: What is disclosed is a semi-solid controlled release pharmaceutical composition containing biocompatible and bioerodible semi-solid lipid matrix incorporating local anesthetics agents to form a semi-solid solution, a method of using the pharmaceutical composition to treat, and a method of making the pharmaceutical composition.
    Type: Application
    Filed: August 28, 2015
    Publication date: December 24, 2015
    Inventors: Hui Rong Shen, Na Gan